Related references
Note: Only part of the references are listed.CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity
Chenyi Yang et al.
CANCER RESEARCH (2015)
Selective Inhibition of HDAC1 and HDAC2 as a Potential Therapeutic Option for B-ALL
Matthew C. Stubbs et al.
CLINICAL CANCER RESEARCH (2015)
The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia
Dominique J. P. M. Stumpel et al.
EUROPEAN JOURNAL OF CANCER (2015)
Dinaciclib is a novel cyclin-dependent kinase inhibitor with significant clinical activity in relapsed and refractory chronic lymphocytic leukemia
J. Flynn et al.
LEUKEMIA (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia
Ajay Abraham et al.
PHARMACOGENOMICS (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single-agent activity in patients with relapsed multiple myeloma
Shaji K. Kumar et al.
BLOOD (2015)
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemia
Bowen Xu et al.
BLOOD (2015)
A comprehensive transcriptional portrait of human cancer cell lines
Christiaan Klijn et al.
NATURE BIOTECHNOLOGY (2015)
Intensified Chemotherapy Without Sct in Infant All: Results From COG P9407 (Cohort 3)
ZoAnn E. Dreyer et al.
PEDIATRIC BLOOD & CANCER (2015)
Trimmomatic: a flexible trimmer for Illumina sequence data
Anthony M. Bolger et al.
BIOINFORMATICS (2014)
Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia
Jeffery M. Klco et al.
CANCER CELL (2014)
Cancer Cell Lines for Drug Discovery and Development
Jennifer L. Wilding et al.
CANCER RESEARCH (2014)
Bortezomib for the treatment of non-Hodgkin's lymphoma
Prithviraj Bose et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
Epigenetics in the hematologic malignancies
Chun Yew Fong et al.
HAEMATOLOGICA (2014)
Update on treatment of light chain amyloidosis
Shameem Mahmood et al.
HAEMATOLOGICA (2014)
Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia
Panagiotis Ntziachristos et al.
NATURE (2014)
Normalization of RNA-seq data using factor analysis of control genes or samples
Davide Risso et al.
NATURE BIOTECHNOLOGY (2014)
Targeting the Wee1 Kinase for Treatment of Pediatric Down Syndrome Acute Myeloid Leukemia
J. Timothy Caldwell et al.
PEDIATRIC BLOOD & CANCER (2014)
Patient-derived models of acquired resistance can identify effective drug combinations for cancer
Adam S. Crystal et al.
SCIENCE (2014)
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Min Yu et al.
SCIENCE (2014)
The evolution of clinical trials for infant acute lymphoblastic leukemia
R. S. Kotecha et al.
BLOOD CANCER JOURNAL (2014)
voom: precision weights unlock linear model analysis tools for RNA-seq read counts
Charity W. Law et al.
GENOME BIOLOGY (2014)
The physiological roles of histone deacetylase (HDAC) 1 and 2: complex co-stars with multiple leading parts
Richard D. W. Kelly et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2013)
New cast for a new era: preclinical cancer drug development revisited
Grit S. Herter-Sprie et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions
Daehwan Kim et al.
GENOME BIOLOGY (2013)
Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
Sylvia Julien et al.
CLINICAL CANCER RESEARCH (2012)
The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression
Thomas Derrien et al.
GENOME RESEARCH (2012)
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
Stephen P. Hunger et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia
D. J. P. M. Stumpel et al.
LEUKEMIA (2012)
Systematic identification of genomic markers of drug sensitivity in cancer cells
Mathew J. Garnett et al.
NATURE (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
Modeling and predicting clinical efficacy for drugs targeting the tumor milieu
Mallika Singh et al.
NATURE BIOTECHNOLOGY (2012)
FusionFinder: A Software Tool to Identify Expressed Gene Fusion Candidates from RNA-Seq Data
Richard W. Francis et al.
PLOS ONE (2012)
MEASURING REPRODUCIBILITY OF HIGH-THROUGHPUT EXPERIMENTS
Qunhua Li et al.
ANNALS OF APPLIED STATISTICS (2011)
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
Richard L. Piekarz et al.
BLOOD (2011)
Analysis of the Role of Hematopoietic Stem-Cell Transplantation in Infants With Acute Lymphoblastic Leukemia in First Remission and MLL Gene Rearrangements: A Report From the Children's Oncology Group
Zoann E. Dreyer et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
Mark A. Dawson et al.
NATURE (2011)
Romidepsin (FK228/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells
Jyoti Panicker et al.
CELL CYCLE (2010)
Mechanisms of Synergistic Antileukemic Interactions between Valproic Acid and Cytarabine in Pediatric Acute Myeloid Leukemia
Chengzhi Xie et al.
CLINICAL CANCER RESEARCH (2010)
Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease
James E. Bradner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Signaling network analysis of ubiquitin-mediated proteins suggests correlations between the 26S proteasome and tumor progression
Cong Fu et al.
MOLECULAR BIOSYSTEMS (2009)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
A xenograft model of infant leukaemia reveals a complex MLL translocation
Michelle J. Henderson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Gemcitabine and cytosine arabinoside cytotoxicity: Association with lymphoblastoid cell expression
Liang Li et al.
CANCER RESEARCH (2008)
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial
Rob Pieters et al.
LANCET (2007)
Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines
A. H. Beesley et al.
BRITISH JOURNAL OF CANCER (2006)
Systems biology and combination therapy in the quest for clinical efficacy
Jonathan B. Fitzgerald et al.
NATURE CHEMICAL BIOLOGY (2006)
Malignant hematopoietic cell lines:: in vitro models for the study of MLL gene alterations
HG Drexler et al.
LEUKEMIA (2004)
Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia
RW Stam et al.
BLOOD (2003)
Share Paper
